638 results on '"Lewis, Andrew L."'
Search Results
102. DC Bead™: a major development in the toolbox for the interventional oncologist
103. Semi-continuous emulsion co-polymerisation of methylmethacrylate and butylacrylate using zwitterionic surfactants as emulsifiers: Evidence of coagulative nucleation above the critical micelle concentration
104. Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering
105. Doxorubicin eluting beads–1:: Effects of drug loading on bead characteristics and drug distribution
106. The interface of medical devices and pharmaceuticals: Part II: the technical challenges of developing combination products were addressed in Part I of this two part article Part II reviews the preclinical tests and shelf-life testing that are required using drug eluting stents and drug eluting beads as examples. Regulatory considerations and ways to simplify development are also examined
107. Irinotecan drug eluting beads for use in chemoembolization: In vitro and in vivo evaluation of drug release properties
108. Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery
109. The biocompatibility of crosslinkable copolymer coatings containing sulfobetaines and phosphobetaines
110. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods
111. Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
112. Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead(TM) (DEBIRI)
113. Physical Vein Models to Quantify the Flow Performance of Sclerosing Foams
114. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies (Preprint)
115. Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance
116. Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model
117. A novel phosphorylcholine-coated contact lens for extended wear use
118. Crosslinkable coatings from phosphorylcholine-based polymers
119. The interface of medical devices and pharmaceuticals: Part I: this two-part article considers the complexities of developing and commercializing combination products using examples from experience with drug-eluting stents and drug-eluting beads. Part I discusses the technical challenges of developing these products
120. Phosphorylcholine-based polymers and their use in the prevention of biofouling
121. Synthesis and characterisation of phosphorylcholine-based polymers useful for coating blood filtration devices
122. Modeling the elastic properties of soft materials from molecular dynamics simulations
123. Thermal and crystallization kinetics of yttrium‐doped phosphate‐based glasses.
124. Corrigendum to “In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1–34 for the treatment of osteoporosis” [Int. J. Pharm. 535 (2018) 113–119]
125. Combined MSC and GLP-1 Therapy Modulates Collagen Remodeling and Apoptosis following Myocardial Infarction
126. pH-sensitive vesicles based on a biocompatible Zwitterionic diblock copolymer
127. Hypoxia as a target for drug combination therapy of liver cancer
128. Nanostructured DPA-MPC-DPA triblock copolymer gel for controlled drug release of ketoprofen and spironolactone
129. Towards Hypoxia-responsive Drug-eluting Embolization Beads
130. Review of the Development of Methods for Characterization of Microspheres for Use in Embolotherapy: Translating Bench to Cathlab
131. Nanotribological Investigation of Polymer Brushes with Lithographically Defined and Systematically Varying Grafting Densities
132. A Review on Phosphorylcholine-Coated Stents
133. Vandetanib-eluting Radiopaque Beads: In vivo Pharmacokinetics, Safety and Toxicity Evaluation following Swine Liver Embolization
134. Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead(TM) (DEBIRI).
135. Effect of Salt on Phosphorylcholine-based Zwitterionic Polymer Brushes
136. Frequent mechanical stress suppresses proliferation of mesenchymal stem cells from human bone marrow without loss of multipotency
137. A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study
138. DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy
139. Fine Adjustment of Interfacial Potential between pH-Responsive Hydrogels and Cell-Sized Particles
140. Chlorine tolerant, multilayer reverse-somosis membranes with high permeate flux and high salt rejection
141. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams
142. Pharmacokinetic differences between subcutaneous and intramuscular administration of lanreotide: Results from a phase I study.
143. Live cell imaging of membrane / cytoskeleton interactions and membrane topology
144. Nile Blue-Based Nanosized pH Sensors for Simultaneous Far-Red and Near-Infrared Live Bioimaging
145. Nanoscale Contact Mechanics of Biocompatible Polyzwitterionic Brushes
146. Polymersome‐mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis ‐infected oral epithelial cells
147. Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts
148. Feasibility of Intracoronary GLP-1 Eluting CellBead™ Infusion in Acute Myocardial Infarction
149. Effect of pH and Temperature on PMPC–PDPA Copolymer Self-Assembly
150. First Human Experience with Directly Image-able Iodinated Embolization Microbeads.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.